NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|767988351|ref|XP_011544072|]
View 

serine/threonine-protein kinase SMG1 isoform X9 [Homo sapiens]

Protein Classification

SMG1 and PIKKc_SMG1 domain-containing protein( domain architecture ID 11239233)

protein containing domains SMG1, PIKKc_SMG1, and FATC

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
SMG1 pfam15785
Serine/threonine-protein kinase smg-1; SMG1 is a family of eukaryotic proteins. In humans this ...
1-612 0e+00

Serine/threonine-protein kinase smg-1; SMG1 is a family of eukaryotic proteins. In humans this family acts as an mRNA-surveillance protein. In C.elegans, SMG1, a phosphatidylinositol kinase-related protein kinase, is a key regulator of growth. Loss of SMG1 leads to hyperactive responses to injury and subsequent growth that continues out of control. It has an antagonistic role to mTOR signalling in these worms and possibly also in higher eukaryotes.


:

Pssm-ID: 464869  Cd Length: 602  Bit Score: 838.35  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351     1 MWALSPTVFALLSKNLMIVHSDLAVHFPAIQYAVLYTLYSHCTRHDHFISSSLSSSSPSLFDGAVISTVTTATKKHFSII 80
Cdd:pfam15785    1 MWALSPSIFELLSTNLRAVDLDLWVRYPAVQYALLNLLYSHCQRHHNFVSSSSLSSSPSLRDGSVQSEVTSPTANNFSTI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351    81 LNLLGILLKKDNLNQDTRKLLMTWALEaavlMKKSETYAP-LFSLPSFHKFCKGLLANTLVEDVNICLQACSSLHALSSS 159
Cdd:pfam15785   81 LNLLAKLLKKDNLNPDNRRLLLKWILE----LRESRTYAPlLFSSPEFLNICRSLLANALKEDVNILLEACACIQAVLSY 156
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   160 LP----DDLLQRCVDVCRVQLVHSGTRIRQAFGKLLKSIPLDVVLS-----------------NNNHTEIQEIslalrsh 218
Cdd:pfam15785  157 NPtfskDELLQLYVDLCLQQLVHSAPNVRQPFGQLLASLPLHVTLSggsilslgmksrrvcvwQQRHSQISAV------- 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   219 msKAPSNTFHPQDFSDVISFILYGNSHRTGKDNWLERLFYSCQRLDKRD--QSTIPRNLLKTDAVLWQWAIWEAAQFTVL 296
Cdd:pfam15785  230 --RRPSNTFHDQVFRDFMEFILYPETHQQGLTNWLEDLFYSCCQLAKQDerQEMLSRCLLRCQALLWFWAQWEAAQYCVL 307
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   297 SKLRTPLGRAQDTFQTIEGIIRSLAAHTLNPDQDVSQWT-TADNDEGHGNNQLRLVLLLQYLENLEKLMYNAYEGCANAL 375
Cdd:pfam15785  308 NRLRTPLGKPQDTFQGIEGIIKMHARHLSGPAKEVSRSAlTGLSLEGLLNNQLRLVLLLQFLENLEKLIYNAYEGCAFAL 387
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   376 TSPPKVIRTFFYTNRQTCQDWLTRIRLSIMRVGLLAGQPAVTVRHGFDLLTEMKTTSLSQGNELEVTIMMVVEALCELHC 455
Cdd:pfam15785  388 PAPPKPVRTFFRTNRPTCQEWLSRIRSSVVIIALHSGQPALAIRHGQQLLTEMKKNSLTQGPEFEQAIVYLAWALCELKE 467
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   456 PEAIQGIAVWSSSIVGKNLLWINSVAQQAEGRFEKASVEYQEHLCAMTGVDCCISSFDksvltlanagrnsaspkhslng 535
Cdd:pfam15785  468 SDAIRGLYVWSKEKVGKSFLWLNSLADQAEGKFEKAAAEYQNLLCEMTGQDCELEPHT---------------------- 525
                          570       580       590       600       610       620       630
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 767988351   536 esRKTVLSKPTDSSPEVINYLGNKACECYISIADWAAVQEWQNAIHDLKKSTSSTSLNLKADF--NYIKSLSSFESGKF 612
Cdd:pfam15785  526 --RQKLSINNSPKPPEVLNFVVAQAMECYQSLGDWSSLMEWQQNVLNLPEDSELNPFNQKSDVesNYIRLLSKFEEGDF 602
PIKKc_SMG1 cd05170
Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical ...
1491-1824 0e+00

Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by genome mutations and by errors during transcription and splicing. SMG-1 phosphorylates Upf1, another central component of NMD, at the C-terminus upon recognition of PTCs. The phosphorylation/dephosphorylation cycle of Upf1 is essential for promoting NMD. In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


:

Pssm-ID: 270714  Cd Length: 304  Bit Score: 613.88  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd05170     1 IQSVGSTVTVLPTKTKPKKLVFLGSDGKRYPYLFKGLEDLHLDERIMQFLSIVNAMLASDNEHRRRRYRARHYSVTPLGP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLFGLYKRWQQREAALQAQKAQDSYQTPQnpgIVPRPSELYYSKIGPALKTVGLSLDVSRRDWPLHVM 1650
Cdd:cd05170    81 RSGLIQWVDGATPLFSLYKRWQQRRAAAQAQKNQDSGSTPP---PVPRPSELFYNKLKPALKAAGIRKSTSRREWPLEVL 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 KAVLEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFE 1730
Cdd:cd05170   158 RQVLEELVAETPRDLLARELWCSSPSSAEWWRVTQRFARSLAVMSMIGYIIGLGDRHLDNILVDLSTGEVVHIDYNVCFE 237
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KGnikvdftfmrakcflvkgqkyndlsfqgKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd05170   238 KG----------------------------KRLRVPEKVPFRLTQNIEHALGPTGVEGTFRLSCEQVLKILRKGRETLLT 289
                         330
                  ....*....|....
gi 767988351 1811 LLEAFVYDPLVDWT 1824
Cdd:cd05170   290 LLEAFVYDPLVDWT 303
FATC pfam02260
FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution ...
3029-3058 3.31e-10

FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution structure of the FATC domain suggests it plays a role in redox-dependent structural and cellular stability.


:

Pssm-ID: 460514 [Multi-domain]  Cd Length: 32  Bit Score: 57.01  E-value: 3.31e-10
                           10        20        30
                   ....*....|....*....|....*....|
gi 767988351  3029 MSVAEQVDYVIKEATNLDNLAQLYEGWTAW 3058
Cdd:pfam02260    2 LSVEGQVDELIQEATDPENLAQMYIGWCPW 31
 
Name Accession Description Interval E-value
SMG1 pfam15785
Serine/threonine-protein kinase smg-1; SMG1 is a family of eukaryotic proteins. In humans this ...
1-612 0e+00

Serine/threonine-protein kinase smg-1; SMG1 is a family of eukaryotic proteins. In humans this family acts as an mRNA-surveillance protein. In C.elegans, SMG1, a phosphatidylinositol kinase-related protein kinase, is a key regulator of growth. Loss of SMG1 leads to hyperactive responses to injury and subsequent growth that continues out of control. It has an antagonistic role to mTOR signalling in these worms and possibly also in higher eukaryotes.


Pssm-ID: 464869  Cd Length: 602  Bit Score: 838.35  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351     1 MWALSPTVFALLSKNLMIVHSDLAVHFPAIQYAVLYTLYSHCTRHDHFISSSLSSSSPSLFDGAVISTVTTATKKHFSII 80
Cdd:pfam15785    1 MWALSPSIFELLSTNLRAVDLDLWVRYPAVQYALLNLLYSHCQRHHNFVSSSSLSSSPSLRDGSVQSEVTSPTANNFSTI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351    81 LNLLGILLKKDNLNQDTRKLLMTWALEaavlMKKSETYAP-LFSLPSFHKFCKGLLANTLVEDVNICLQACSSLHALSSS 159
Cdd:pfam15785   81 LNLLAKLLKKDNLNPDNRRLLLKWILE----LRESRTYAPlLFSSPEFLNICRSLLANALKEDVNILLEACACIQAVLSY 156
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   160 LP----DDLLQRCVDVCRVQLVHSGTRIRQAFGKLLKSIPLDVVLS-----------------NNNHTEIQEIslalrsh 218
Cdd:pfam15785  157 NPtfskDELLQLYVDLCLQQLVHSAPNVRQPFGQLLASLPLHVTLSggsilslgmksrrvcvwQQRHSQISAV------- 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   219 msKAPSNTFHPQDFSDVISFILYGNSHRTGKDNWLERLFYSCQRLDKRD--QSTIPRNLLKTDAVLWQWAIWEAAQFTVL 296
Cdd:pfam15785  230 --RRPSNTFHDQVFRDFMEFILYPETHQQGLTNWLEDLFYSCCQLAKQDerQEMLSRCLLRCQALLWFWAQWEAAQYCVL 307
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   297 SKLRTPLGRAQDTFQTIEGIIRSLAAHTLNPDQDVSQWT-TADNDEGHGNNQLRLVLLLQYLENLEKLMYNAYEGCANAL 375
Cdd:pfam15785  308 NRLRTPLGKPQDTFQGIEGIIKMHARHLSGPAKEVSRSAlTGLSLEGLLNNQLRLVLLLQFLENLEKLIYNAYEGCAFAL 387
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   376 TSPPKVIRTFFYTNRQTCQDWLTRIRLSIMRVGLLAGQPAVTVRHGFDLLTEMKTTSLSQGNELEVTIMMVVEALCELHC 455
Cdd:pfam15785  388 PAPPKPVRTFFRTNRPTCQEWLSRIRSSVVIIALHSGQPALAIRHGQQLLTEMKKNSLTQGPEFEQAIVYLAWALCELKE 467
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   456 PEAIQGIAVWSSSIVGKNLLWINSVAQQAEGRFEKASVEYQEHLCAMTGVDCCISSFDksvltlanagrnsaspkhslng 535
Cdd:pfam15785  468 SDAIRGLYVWSKEKVGKSFLWLNSLADQAEGKFEKAAAEYQNLLCEMTGQDCELEPHT---------------------- 525
                          570       580       590       600       610       620       630
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 767988351   536 esRKTVLSKPTDSSPEVINYLGNKACECYISIADWAAVQEWQNAIHDLKKSTSSTSLNLKADF--NYIKSLSSFESGKF 612
Cdd:pfam15785  526 --RQKLSINNSPKPPEVLNFVVAQAMECYQSLGDWSSLMEWQQNVLNLPEDSELNPFNQKSDVesNYIRLLSKFEEGDF 602
PIKKc_SMG1 cd05170
Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical ...
1491-1824 0e+00

Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by genome mutations and by errors during transcription and splicing. SMG-1 phosphorylates Upf1, another central component of NMD, at the C-terminus upon recognition of PTCs. The phosphorylation/dephosphorylation cycle of Upf1 is essential for promoting NMD. In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270714  Cd Length: 304  Bit Score: 613.88  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd05170     1 IQSVGSTVTVLPTKTKPKKLVFLGSDGKRYPYLFKGLEDLHLDERIMQFLSIVNAMLASDNEHRRRRYRARHYSVTPLGP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLFGLYKRWQQREAALQAQKAQDSYQTPQnpgIVPRPSELYYSKIGPALKTVGLSLDVSRRDWPLHVM 1650
Cdd:cd05170    81 RSGLIQWVDGATPLFSLYKRWQQRRAAAQAQKNQDSGSTPP---PVPRPSELFYNKLKPALKAAGIRKSTSRREWPLEVL 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 KAVLEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFE 1730
Cdd:cd05170   158 RQVLEELVAETPRDLLARELWCSSPSSAEWWRVTQRFARSLAVMSMIGYIIGLGDRHLDNILVDLSTGEVVHIDYNVCFE 237
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KGnikvdftfmrakcflvkgqkyndlsfqgKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd05170   238 KG----------------------------KRLRVPEKVPFRLTQNIEHALGPTGVEGTFRLSCEQVLKILRKGRETLLT 289
                         330
                  ....*....|....
gi 767988351 1811 LLEAFVYDPLVDWT 1824
Cdd:cd05170   290 LLEAFVYDPLVDWT 303
PI3_PI4_kinase pfam00454
Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid ...
1519-1824 4.06e-59

Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid kinase activity and are protein kinases,.


Pssm-ID: 395364 [Multi-domain]  Cd Length: 241  Bit Score: 204.87  E-value: 4.06e-59
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351  1519 SYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRqetPRFHARHYSVTPLGTRSGLIQWVDGATPLfglykrwqqreAAL 1598
Cdd:pfam00454    1 GYGGIYKVGDDLRQDELILQVFKLMDEELSKDNL---DLRRLKPYSVIPLGPKCGIIEWVPNSETL-----------AYI 66
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351  1599 QaqkaqdsyqtpqnpgivprpSELYYSKIGPALKtvglsldVSRRDWPLHVMKAVLEELMEA--TPPNLLAKELWSSCTT 1676
Cdd:pfam00454   67 L--------------------DEYGENGVPPTAM-------VKILHSALNYPKLKLEFESRIslPPKVGLLQWFVKKSPD 119
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351  1677 PDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFEKgnikvdftfmrakcflvkgqkyndl 1756
Cdd:pfam00454  120 AEEWGEARKNFVRSCAGYSVLDYILGNGDRHLDNILVDKTTGKLFHIDFGLCLPD------------------------- 174
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 767988351  1757 sfQGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWT 1824
Cdd:pfam00454  175 --AGKDLPFPEKVPFRLTREMVYAMGPSGDEGLFRELCETAYEALRRNLNLLTNLLKLMVADGLPDWS 240
TEL1 COG5032
Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];
1410-1823 4.39e-53

Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];


Pssm-ID: 227365 [Multi-domain]  Cd Length: 2105  Bit Score: 207.71  E-value: 4.39e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1410 FQDNYGDAIENALEKLKTPLNPakpgsSWIPFKEIMLSLQQRAQKRASYILRLEEISPwLAAMTNTEIALPGEV-SARDT 1488
Cdd:COG5032  1691 LIKKSPRKIRKKFKIDISLLNL-----SRKLYISVLRSIRKRLKRLLELRLKKVSPKL-LLFHAFLEIKLPGQYlLDKPF 1764
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1489 VTIHSVGGTITILPTKT-KPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTP 1567
Cdd:COG5032  1765 VLIERFEPEVSVVKSHLqRPRRLTIRGSDGKLYSFIVKGGDDLRQDELALQLIRLMNKILKKDKETRRRDLWIRPYKVIP 1844
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1568 LGTRSGLIQWVDGATPLFGLYK--RWQQREAALQAQKAQDSYQtpqnpgivprpselyyskigpaLKTVGLSLDVsrrdw 1645
Cdd:COG5032  1845 LSPGSGIIEWVPNSDTLHSILReyHKRKNISIDQEKKLAARLD----------------------NLKLLLKDEF----- 1897
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1646 plhvmkavlEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDy 1725
Cdd:COG5032  1898 ---------FTKATLKSPPVLYDWFSESFPNPEDWLTARTNFARSLAVYSVIGYILGLGDRHPGNILIDRSSGHVIHID- 1967
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1726 nvcfekgnikvdFTFMrakcflvkgqkyndLSFQGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGR 1805
Cdd:COG5032  1968 ------------FGFI--------------LFNAPGRFPFPEKVPFRLTRNIVEAMGVSGVEGSFRELCETAFRALRKNA 2021
                         410
                  ....*....|....*...
gi 767988351 1806 ETLLTLLEAFVYDPLVDW 1823
Cdd:COG5032  2022 DSLMNVLELFVRDPLIEW 2039
PI3Kc smart00146
Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in ...
1523-1824 3.83e-51

Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in a variety of processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, and apoptosis. These homologues may be either lipid kinases and/or protein kinases: the former phosphorylate the 3-position in the inositol ring of inositol phospholipids. The ataxia telangiectesia-mutated gene produced, the targets of rapamycin (TOR) and the DNA-dependent kinase have not been found to possess lipid kinase activity. Some of this family possess PI-4 kinase activities.


Pssm-ID: 214538 [Multi-domain]  Cd Length: 240  Bit Score: 181.73  E-value: 3.83e-51
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   1523 LFKGLEDLHLDERIMQFLSIVNTMFAtiNRQETPR--FHARHYSVTPLGTRSGLIQWVDGATPLFGL---YKRWQQREAA 1597
Cdd:smart00146    2 IFKGGDDLRQDERVLQLLRLMNKLLQ--KDKETRRrdLHLRPYKVIPTGPKSGLIEVVPNSTTLHEIlkeYRKQKGKVLD 79
                            90       100       110       120       130       140       150       160
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   1598 LQAQKAqdsyqtpqnpgivprpselyyskigpalktvglsldvSRRDWPLHVMKAVLEelmeaTPPNLLAKELWSSCTTP 1677
Cdd:smart00146   80 LRSQTA-------------------------------------TRLKKLELFLEATGK-----FPDPVLYDWFTKKFPDP 117
                           170       180       190       200       210       220       230       240
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   1678 DE-WWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDYNVCFEKGNIKVDFtfmrakcflvkgqkyndl 1756
Cdd:smart00146  118 SEdYFEARKNFTRSCAGYSVITYILGLGDRHNDNIMLD-KTGHLFHIDFGFILGNGPKLFGF------------------ 178
                           250       260       270       280       290       300
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 767988351   1757 sfqgkslrvPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWT 1824
Cdd:smart00146  179 ---------PERVPFRLTPEMVDVMGDSGYFGLFRSLCERALRALRKNSNLIMSLLELMLYDGLPDWR 237
FATC pfam02260
FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution ...
3029-3058 3.31e-10

FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution structure of the FATC domain suggests it plays a role in redox-dependent structural and cellular stability.


Pssm-ID: 460514 [Multi-domain]  Cd Length: 32  Bit Score: 57.01  E-value: 3.31e-10
                           10        20        30
                   ....*....|....*....|....*....|
gi 767988351  3029 MSVAEQVDYVIKEATNLDNLAQLYEGWTAW 3058
Cdd:pfam02260    2 LSVEGQVDELIQEATDPENLAQMYIGWCPW 31
 
Name Accession Description Interval E-value
SMG1 pfam15785
Serine/threonine-protein kinase smg-1; SMG1 is a family of eukaryotic proteins. In humans this ...
1-612 0e+00

Serine/threonine-protein kinase smg-1; SMG1 is a family of eukaryotic proteins. In humans this family acts as an mRNA-surveillance protein. In C.elegans, SMG1, a phosphatidylinositol kinase-related protein kinase, is a key regulator of growth. Loss of SMG1 leads to hyperactive responses to injury and subsequent growth that continues out of control. It has an antagonistic role to mTOR signalling in these worms and possibly also in higher eukaryotes.


Pssm-ID: 464869  Cd Length: 602  Bit Score: 838.35  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351     1 MWALSPTVFALLSKNLMIVHSDLAVHFPAIQYAVLYTLYSHCTRHDHFISSSLSSSSPSLFDGAVISTVTTATKKHFSII 80
Cdd:pfam15785    1 MWALSPSIFELLSTNLRAVDLDLWVRYPAVQYALLNLLYSHCQRHHNFVSSSSLSSSPSLRDGSVQSEVTSPTANNFSTI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351    81 LNLLGILLKKDNLNQDTRKLLMTWALEaavlMKKSETYAP-LFSLPSFHKFCKGLLANTLVEDVNICLQACSSLHALSSS 159
Cdd:pfam15785   81 LNLLAKLLKKDNLNPDNRRLLLKWILE----LRESRTYAPlLFSSPEFLNICRSLLANALKEDVNILLEACACIQAVLSY 156
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   160 LP----DDLLQRCVDVCRVQLVHSGTRIRQAFGKLLKSIPLDVVLS-----------------NNNHTEIQEIslalrsh 218
Cdd:pfam15785  157 NPtfskDELLQLYVDLCLQQLVHSAPNVRQPFGQLLASLPLHVTLSggsilslgmksrrvcvwQQRHSQISAV------- 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   219 msKAPSNTFHPQDFSDVISFILYGNSHRTGKDNWLERLFYSCQRLDKRD--QSTIPRNLLKTDAVLWQWAIWEAAQFTVL 296
Cdd:pfam15785  230 --RRPSNTFHDQVFRDFMEFILYPETHQQGLTNWLEDLFYSCCQLAKQDerQEMLSRCLLRCQALLWFWAQWEAAQYCVL 307
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   297 SKLRTPLGRAQDTFQTIEGIIRSLAAHTLNPDQDVSQWT-TADNDEGHGNNQLRLVLLLQYLENLEKLMYNAYEGCANAL 375
Cdd:pfam15785  308 NRLRTPLGKPQDTFQGIEGIIKMHARHLSGPAKEVSRSAlTGLSLEGLLNNQLRLVLLLQFLENLEKLIYNAYEGCAFAL 387
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   376 TSPPKVIRTFFYTNRQTCQDWLTRIRLSIMRVGLLAGQPAVTVRHGFDLLTEMKTTSLSQGNELEVTIMMVVEALCELHC 455
Cdd:pfam15785  388 PAPPKPVRTFFRTNRPTCQEWLSRIRSSVVIIALHSGQPALAIRHGQQLLTEMKKNSLTQGPEFEQAIVYLAWALCELKE 467
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   456 PEAIQGIAVWSSSIVGKNLLWINSVAQQAEGRFEKASVEYQEHLCAMTGVDCCISSFDksvltlanagrnsaspkhslng 535
Cdd:pfam15785  468 SDAIRGLYVWSKEKVGKSFLWLNSLADQAEGKFEKAAAEYQNLLCEMTGQDCELEPHT---------------------- 525
                          570       580       590       600       610       620       630
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 767988351   536 esRKTVLSKPTDSSPEVINYLGNKACECYISIADWAAVQEWQNAIHDLKKSTSSTSLNLKADF--NYIKSLSSFESGKF 612
Cdd:pfam15785  526 --RQKLSINNSPKPPEVLNFVVAQAMECYQSLGDWSSLMEWQQNVLNLPEDSELNPFNQKSDVesNYIRLLSKFEEGDF 602
PIKKc_SMG1 cd05170
Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical ...
1491-1824 0e+00

Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by genome mutations and by errors during transcription and splicing. SMG-1 phosphorylates Upf1, another central component of NMD, at the C-terminus upon recognition of PTCs. The phosphorylation/dephosphorylation cycle of Upf1 is essential for promoting NMD. In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270714  Cd Length: 304  Bit Score: 613.88  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd05170     1 IQSVGSTVTVLPTKTKPKKLVFLGSDGKRYPYLFKGLEDLHLDERIMQFLSIVNAMLASDNEHRRRRYRARHYSVTPLGP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLFGLYKRWQQREAALQAQKAQDSYQTPQnpgIVPRPSELYYSKIGPALKTVGLSLDVSRRDWPLHVM 1650
Cdd:cd05170    81 RSGLIQWVDGATPLFSLYKRWQQRRAAAQAQKNQDSGSTPP---PVPRPSELFYNKLKPALKAAGIRKSTSRREWPLEVL 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 KAVLEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFE 1730
Cdd:cd05170   158 RQVLEELVAETPRDLLARELWCSSPSSAEWWRVTQRFARSLAVMSMIGYIIGLGDRHLDNILVDLSTGEVVHIDYNVCFE 237
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KGnikvdftfmrakcflvkgqkyndlsfqgKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd05170   238 KG----------------------------KRLRVPEKVPFRLTQNIEHALGPTGVEGTFRLSCEQVLKILRKGRETLLT 289
                         330
                  ....*....|....
gi 767988351 1811 LLEAFVYDPLVDWT 1824
Cdd:cd05170   290 LLEAFVYDPLVDWT 303
PIKKc cd05164
Catalytic domain of Phosphoinositide 3-kinase-related protein kinases; PIKK subfamily members ...
1491-1818 1.60e-96

Catalytic domain of Phosphoinositide 3-kinase-related protein kinases; PIKK subfamily members include ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia and Rad3-related), TOR (Target of rapamycin), SMG-1 (Suppressor of morphogenetic effect on genitalia-1), and DNA-PK (DNA-dependent protein kinase). PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). They show strong preference for phosphorylating serine/threonine residues followed by a glutamine and are also referred to as (S/T)-Q-directed kinases. They all contain a FATC (FRAP, ATM and TRRAP, C-terminal) domain. PIKKs have diverse functions including cell-cycle checkpoints, genome surveillance, mRNA surveillance, and translation control. The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270708 [Multi-domain]  Cd Length: 222  Bit Score: 311.13  E-value: 1.60e-96
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd05164     1 IASFDPRVRILASLQKPKKITILGSDGKEYPFLVKGDDDLRKDERVMQLFQLLNTLLEKDKETRKRNLTIRTYSVVPLSS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLFGLYKRWqqreaalqaqkaqdsyqtpqnpgivprpselyyskigpalktvglsldvsrrdwplhvm 1650
Cdd:cd05164    81 QSGLIEWVDNTTTLKPVLKKW----------------------------------------------------------- 101
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 kavleelmeatppnllakeLWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFE 1730
Cdd:cd05164   102 -------------------FNETFPDPTQWYEARSNYTKSTAVMSMVGYIIGLGDRHLENILIDTKTGEVVHIDFGMIFN 162
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KGnikvdftfmrakcflvkgqkyndlsfqgKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd05164   163 KG----------------------------KTLPVPEIVPFRLTRNIINGMGPTGVEGLFRKSCEQVLRVFRKHKDKLIT 214

                  ....*...
gi 767988351 1811 LLEAFVYD 1818
Cdd:cd05164   215 FLDTFLYD 222
PIKKc_TOR cd05169
Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic ...
1491-1823 1.37e-88

Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic domain, and a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. It is also called FRAP (FK506 binding protein 12-rapamycin associated protein). TOR is a central component of the eukaryotic growth regulatory network. It controls the expression of many genes transcribed by all three RNA polymerases. It associates with other proteins to form two distinct complexes, TORC1 and TORC2. TORC1 is involved in diverse growth-related functions including protein synthesis, nutrient use and transport, autophagy and stress responses. TORC2 is involved in organizing cytoskeletal structures. TOR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270713 [Multi-domain]  Cd Length: 279  Bit Score: 290.92  E-value: 1.37e-88
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd05169     1 ISSFDPTLEVITSKQRPRKLTIVGSDGKEYKFLLKGHEDLRLDERVMQLFGLVNTLLKNDSETSRRNLSIQRYSVIPLSP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLFGLYKRW-QQREAALQAQKAQDSYQTPQnpgivprpselYYSkigpalktvglsldvsrrdwpLHV 1649
Cdd:cd05169    81 NSGLIGWVPGCDTLHSLIRDYrEKRKIPLNIEHRLMLQMAPD-----------YDN---------------------LTL 128
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1650 M--KAVLEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNV 1727
Cdd:cd05169   129 IqkVEVFEYALENTPGDDLRRVLWLKSPSSEAWLERRTNFTRSLAVMSMVGYILGLGDRHPSNIMLDRLTGKVIHIDFGD 208
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1728 CFEKgnikvdfTFMRAKCflvkgqkyndlsfqgkslrvPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRET 1807
Cdd:cd05169   209 CFEV-------AMHREKF--------------------PEKVPFRLTRMLVNAMEVSGVEGTFRSTCEDVMRVLRENKDS 261
                         330
                  ....*....|....*.
gi 767988351 1808 LLTLLEAFVYDPLVDW 1823
Cdd:cd05169   262 LMAVLEAFVHDPLISW 277
PIKKc_ATR cd00892
Catalytic domain of Ataxia telangiectasia and Rad3-related proteins; ATR is also referred to ...
1491-1824 4.06e-79

Catalytic domain of Ataxia telangiectasia and Rad3-related proteins; ATR is also referred to as Mei-41 (Drosophila), Esr1/Mec1p (Saccharomyces cerevisiae), Rad3 (Schizosaccharomyces pombe), and FRAP-related protein (human). ATR contains a UME domain of unknown function, a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. Together with its downstream effector kinase, Chk1, ATR plays a central role in regulating the replication checkpoint. ATR stabilizes replication forks by promoting the association of DNA polymerases with the fork. Preventing fork collapse is essential in preserving genomic integrity. ATR also plays a role in normal cell growth and in response to DNA damage. ATR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270625 [Multi-domain]  Cd Length: 237  Bit Score: 262.06  E-value: 4.06e-79
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd00892     1 ISGFEDEVEIMPSLQKPKKITLVGSDGKKYPFLCKPKDDLRKDARMMEFNTLINRLLSKDPESRRRNLHIRTYAVIPLNE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGatplfglykrwqqreaalqaqkaqdsyqtpqnpgivprpselyyskigpalktvglsldvsrrdwpLHVM 1650
Cdd:cd00892    81 ECGIIEWVPN------------------------------------------------------------------TVTL 94
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 KAVLEELMeatPPnLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFE 1730
Cdd:cd00892    95 RSILSTLY---PP-VLHEWFLKNFPDPTAWYEARNNYTRSTAVMSMVGYILGLGDRHGENILFDSTTGDVVHVDFDCLFD 170
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KGnikvdftfmrakcflvkgqkyndlsfqgKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd00892   171 KG----------------------------LTLEVPERVPFRLTQNMVDAMGVTGVEGTFRRTCEVTLRVLRENRETLMS 222
                         330
                  ....*....|....
gi 767988351 1811 LLEAFVYDPLVDWT 1824
Cdd:cd00892   223 VLETFVHDPLVEWS 236
PIKKc_ATM cd05171
Catalytic domain of Ataxia Telangiectasia Mutated; ATM is critical in the response to DNA ...
1491-1824 3.10e-74

Catalytic domain of Ataxia Telangiectasia Mutated; ATM is critical in the response to DNA double strand breaks (DSBs) caused by radiation. It is activated at the site of a DSB and phosphorylates key substrates that trigger pathways that regulate DNA repair and cell cycle checkpoints at the G1/S, S phase, and G2/M transition. Patients with the human genetic disorder Ataxia telangiectasia (A-T), caused by truncating mutations in ATM, show genome instability, increased cancer risk, immunodeficiency, compromised mobility, and neurodegeneration. A-T displays clinical heterogeneity, which is correlated to the degree of retained ATM activity. ATM contains a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. It is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270715 [Multi-domain]  Cd Length: 282  Bit Score: 249.76  E-value: 3.10e-74
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFAtiNRQET--PRFHARHYSVTPL 1568
Cdd:cd05171     1 ISRFEDTFTLAGGINLPKIITCIGSDGKKYKQLVKGGDDLRQDAVMEQVFELVNQLLK--RDKETrkRKLRIRTYKVVPL 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1569 GTRSGLIQWVDGATPLfGLYKRwqqreAALQAQKAQDSYqtpqnpgivpRPSELYYSKIGPALKTVGLSLDVSRRdwplh 1648
Cdd:cd05171    79 SPRSGVLEFVENTIPL-GEYLV-----GASSKSGAHARY----------RPKDWTASTCRKKMREKAKASAEERL----- 137
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1649 vmkAVLEELMEATPPnLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVC 1728
Cdd:cd05171   138 ---KVFDEICKNFKP-VFRHFFLEKFPDPSDWFERRLAYTRSVATSSIVGYILGLGDRHLNNILIDQKTGELVHIDLGIA 213
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1729 FEkgnikvdftfmrakcflvkgqkyndlsfQGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETL 1808
Cdd:cd05171   214 FE----------------------------QGKLLPIPETVPFRLTRDIVDGMGITGVEGVFRRCCEETLRVLRENKEAL 265
                         330
                  ....*....|....*.
gi 767988351 1809 LTLLEAFVYDPLVDWT 1824
Cdd:cd05171   266 LTILEVLLYDPLYSWT 281
PI3_PI4_kinase pfam00454
Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid ...
1519-1824 4.06e-59

Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid kinase activity and are protein kinases,.


Pssm-ID: 395364 [Multi-domain]  Cd Length: 241  Bit Score: 204.87  E-value: 4.06e-59
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351  1519 SYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRqetPRFHARHYSVTPLGTRSGLIQWVDGATPLfglykrwqqreAAL 1598
Cdd:pfam00454    1 GYGGIYKVGDDLRQDELILQVFKLMDEELSKDNL---DLRRLKPYSVIPLGPKCGIIEWVPNSETL-----------AYI 66
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351  1599 QaqkaqdsyqtpqnpgivprpSELYYSKIGPALKtvglsldVSRRDWPLHVMKAVLEELMEA--TPPNLLAKELWSSCTT 1676
Cdd:pfam00454   67 L--------------------DEYGENGVPPTAM-------VKILHSALNYPKLKLEFESRIslPPKVGLLQWFVKKSPD 119
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351  1677 PDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFEKgnikvdftfmrakcflvkgqkyndl 1756
Cdd:pfam00454  120 AEEWGEARKNFVRSCAGYSVLDYILGNGDRHLDNILVDKTTGKLFHIDFGLCLPD------------------------- 174
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 767988351  1757 sfQGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWT 1824
Cdd:pfam00454  175 --AGKDLPFPEKVPFRLTREMVYAMGPSGDEGLFRELCETAYEALRRNLNLLTNLLKLMVADGLPDWS 240
TEL1 COG5032
Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];
1410-1823 4.39e-53

Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];


Pssm-ID: 227365 [Multi-domain]  Cd Length: 2105  Bit Score: 207.71  E-value: 4.39e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1410 FQDNYGDAIENALEKLKTPLNPakpgsSWIPFKEIMLSLQQRAQKRASYILRLEEISPwLAAMTNTEIALPGEV-SARDT 1488
Cdd:COG5032  1691 LIKKSPRKIRKKFKIDISLLNL-----SRKLYISVLRSIRKRLKRLLELRLKKVSPKL-LLFHAFLEIKLPGQYlLDKPF 1764
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1489 VTIHSVGGTITILPTKT-KPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTP 1567
Cdd:COG5032  1765 VLIERFEPEVSVVKSHLqRPRRLTIRGSDGKLYSFIVKGGDDLRQDELALQLIRLMNKILKKDKETRRRDLWIRPYKVIP 1844
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1568 LGTRSGLIQWVDGATPLFGLYK--RWQQREAALQAQKAQDSYQtpqnpgivprpselyyskigpaLKTVGLSLDVsrrdw 1645
Cdd:COG5032  1845 LSPGSGIIEWVPNSDTLHSILReyHKRKNISIDQEKKLAARLD----------------------NLKLLLKDEF----- 1897
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1646 plhvmkavlEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDy 1725
Cdd:COG5032  1898 ---------FTKATLKSPPVLYDWFSESFPNPEDWLTARTNFARSLAVYSVIGYILGLGDRHPGNILIDRSSGHVIHID- 1967
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1726 nvcfekgnikvdFTFMrakcflvkgqkyndLSFQGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGR 1805
Cdd:COG5032  1968 ------------FGFI--------------LFNAPGRFPFPEKVPFRLTRNIVEAMGVSGVEGSFRELCETAFRALRKNA 2021
                         410
                  ....*....|....*...
gi 767988351 1806 ETLLTLLEAFVYDPLVDW 1823
Cdd:COG5032  2022 DSLMNVLELFVRDPLIEW 2039
PI3Kc smart00146
Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in ...
1523-1824 3.83e-51

Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in a variety of processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, and apoptosis. These homologues may be either lipid kinases and/or protein kinases: the former phosphorylate the 3-position in the inositol ring of inositol phospholipids. The ataxia telangiectesia-mutated gene produced, the targets of rapamycin (TOR) and the DNA-dependent kinase have not been found to possess lipid kinase activity. Some of this family possess PI-4 kinase activities.


Pssm-ID: 214538 [Multi-domain]  Cd Length: 240  Bit Score: 181.73  E-value: 3.83e-51
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   1523 LFKGLEDLHLDERIMQFLSIVNTMFAtiNRQETPR--FHARHYSVTPLGTRSGLIQWVDGATPLFGL---YKRWQQREAA 1597
Cdd:smart00146    2 IFKGGDDLRQDERVLQLLRLMNKLLQ--KDKETRRrdLHLRPYKVIPTGPKSGLIEVVPNSTTLHEIlkeYRKQKGKVLD 79
                            90       100       110       120       130       140       150       160
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   1598 LQAQKAqdsyqtpqnpgivprpselyyskigpalktvglsldvSRRDWPLHVMKAVLEelmeaTPPNLLAKELWSSCTTP 1677
Cdd:smart00146   80 LRSQTA-------------------------------------TRLKKLELFLEATGK-----FPDPVLYDWFTKKFPDP 117
                           170       180       190       200       210       220       230       240
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351   1678 DE-WWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDYNVCFEKGNIKVDFtfmrakcflvkgqkyndl 1756
Cdd:smart00146  118 SEdYFEARKNFTRSCAGYSVITYILGLGDRHNDNIMLD-KTGHLFHIDFGFILGNGPKLFGF------------------ 178
                           250       260       270       280       290       300
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 767988351   1757 sfqgkslrvPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWT 1824
Cdd:smart00146  179 ---------PERVPFRLTPEMVDVMGDSGYFGLFRSLCERALRALRKNSNLIMSLLELMLYDGLPDWR 237
PIKKc_DNA-PK cd05172
Catalytic domain of DNA-dependent protein kinase; DNA-PK is comprised of a regulatory subunit, ...
1491-1823 4.56e-50

Catalytic domain of DNA-dependent protein kinase; DNA-PK is comprised of a regulatory subunit, containing the Ku70/80 subunit, and a catalytic subunit, which contains a NUC194 domain of unknown function, a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. It is part of a multi-component system involved in non-homologous end joining (NHEJ), a process of repairing double strand breaks (DSBs) by joining together two free DNA ends of little homology. DNA-PK functions as a molecular sensor for DNA damage that enhances the signal via phosphorylation of downstream targets. It may also act as a protein scaffold that aids the localization of DNA repair proteins to the site of DNA damage. DNA-PK also plays a role in the maintenance of telomeric stability and the prevention of chromosomal end fusion. DNA-PK is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270716 [Multi-domain]  Cd Length: 235  Bit Score: 178.54  E-value: 4.56e-50
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGT 1570
Cdd:cd05172     1 IVGFDPRVLVLSSKRRPKRITIRGSDEKEYKFLVKGGEDLRQDQRIQQLFDVMNNILASDPACRQRRLRIRTYQVIPMTS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLfglykrwqqreaalqaqkaqdsyqtpqnpgivprpselyyskigpalktvglsldvsrrdwplhvm 1650
Cdd:cd05172    81 RLGLIEWVDNTTPL------------------------------------------------------------------ 94
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 KAVLEElmeatppNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFE 1730
Cdd:cd05172    95 KEILEN-------DLLRRALLSLASSPEAFLALRSNFARSLAAMSICGYILGIGDRHLSNFLVDLSTGRLIGIDFGHAFG 167
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KGNIKvdftfmrakcflvkgqkyndlsfqgksLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd05172   168 SATQF---------------------------LPIPELVPFRLTRQLLNLLQPLDARGLLRSDMVHVLRALRAGRDLLLA 220
                         330
                  ....*....|...
gi 767988351 1811 LLEAFVYDPLVDW 1823
Cdd:cd05172   221 TMDVFVKEPLLDW 233
PI3Kc_like cd00142
Catalytic domain of Phosphoinositide 3-kinase and similar proteins; Members of the family ...
1491-1818 2.51e-34

Catalytic domain of Phosphoinositide 3-kinase and similar proteins; Members of the family include PI3K, phosphoinositide 4-kinase (PI4K), PI3K-related protein kinases (PIKKs), and TRansformation/tRanscription domain-Associated Protein (TRAPP). PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives, while PI4K catalyze the phosphorylation of the 4-hydroxyl of PtdIns. PIKKs are protein kinases that catalyze the phosphorylation of serine/threonine residues, especially those that are followed by a glutamine. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. PI4Ks produce PtdIns(4)P, the major precursor to important signaling phosphoinositides. PIKKs have diverse functions including cell-cycle checkpoints, genome surveillance, mRNA surveillance, and translation control. The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270621 [Multi-domain]  Cd Length: 216  Bit Score: 132.46  E-value: 2.51e-34
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1491 IHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFatinRQETPRFHARHYSVTPLGT 1570
Cdd:cd00142     1 NALDVGILKVIHSKQRPKKITLIGADGKTYSFLLKRRDDLRKDERSFQFMRLIQSIL----EKESVNLVLPPYKVIPLSE 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1571 RSGLIQWVDGATPLFGLykrwqqreaalqaqkaqdsyqtpqnpgivprpselyyskigpalktvglsldvsrrdwplhvm 1650
Cdd:cd00142    77 NSGLIEIVKDAQTIEDL--------------------------------------------------------------- 93
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1651 kavleelmeatppnllAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDYNVCFE 1730
Cdd:cd00142    94 ----------------LKSLWRKSPSSQSWLNRRENFSCSLAGYSVLGYIFGIGDRHPSNIMIE-PSGNIFHIDFGFIFS 156
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1731 KgnikvdftfmrakcflvkgqkyndlsfqGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLT 1810
Cdd:cd00142   157 G----------------------------RKLAEGVETVPFRLTPMLENAMGTAGVNGPFQISMVKIMEILREHADLIVP 208

                  ....*...
gi 767988351 1811 LLEAFVYD 1818
Cdd:cd00142   209 ILEHSLRD 216
PIKK_TRRAP cd05163
Pseudokinase domain of TRansformation/tRanscription domain-Associated Protein; TRRAP belongs ...
1508-1790 7.26e-12

Pseudokinase domain of TRansformation/tRanscription domain-Associated Protein; TRRAP belongs to the the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. It contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain and has a large molecular weight. Unlike most PIKK proteins, however, it contains an inactive PI3K-like pseudokinase domain, which lacks the conserved residues necessary for ATP binding and catalytic activity. TRRAP also contains many motifs that may be critical for protein-protein interactions. TRRAP is a common component of many histone acetyltransferase (HAT) complexes, and is responsible for the recruitment of these complexes to chromatin during transcription, replication, and DNA repair. TRRAP also exists in non-HAT complexes such as the p400 and MRN complexes, which are implicated in ATP-dependent remodeling and DNA repair, respectively. The TRRAP pseudokinase domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270707  Cd Length: 252  Bit Score: 68.32  E-value: 7.26e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1508 KKLLFLGSDGKSYPYL--FKGLEDLHLDERIMQFLSIVNTMFATinRQETPRFHARHY--SVTPLGTRSGLIQwvdgatp 1583
Cdd:cd05163    19 RRLTIRGHDGSKYPFLvqTPSARHSRREERVMQLFRLLNRVLER--KKETRRRNLQFHvpIVVPLSPQVRLVE------- 89
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1584 lfglykrwqqreaalqaqkAQDSYQTPQNPgivprpselyYSKigpalktvglsldvsrrdwpLHVMKAVLEELMeatPP 1663
Cdd:cd05163    90 -------------------DDPSYISLQDI----------YEK--------------------LEILNEIQSKMV---PE 117
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1664 NLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYnvcfekgnikvdftfmra 1743
Cdd:cd05163   118 TILSNYFLRTMPSPSDLWLFRKQFTLQLALSSFMTYVLSLGNRTPHRILISRSTGNVFMTDF------------------ 179
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*..
gi 767988351 1744 kcflvkgqkYNDLSFQGKSLRVPEKVPFRMTQNIETALGVTGVEGVF 1790
Cdd:cd05163   180 ---------LPSINSQGPLLDNNEPVPFRLTPNIQHFIGPIGVEGLL 217
PI3Kc_III cd00896
Catalytic domain of Class III Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
1498-1725 5.52e-11

Catalytic domain of Class III Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. Class III PI3Ks, also called Vps34 (vacuolar protein sorting 34), contain an N-terminal lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They phosphorylate only the substrate PtdIns. They interact with a regulatory subunit, Vps15, to form a membrane-associated complex. Class III PI3Ks are involved in protein and vesicular trafficking and sorting, autophagy, trimeric G-protein signaling, and phagocytosis. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270628 [Multi-domain]  Cd Length: 346  Bit Score: 67.17  E-value: 5.52e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1498 ITILPTKTK-------PKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFatinRQE------TPrfharhYS 1564
Cdd:cd00896    64 TGIIPEKSTvfksalmPLKLTFKTLDGGEYKVIFKHGDDLRQDQLVLQIITLMDRLL----KKEnldlklTP------YK 133
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1565 VTPLGTRSGLIQWVDGATPLFGLYKRWQQREAALQAQkaqdsyqtpqnpgivpRPSElyyskigpalktvglsldvsrrD 1644
Cdd:cd00896   134 VLATSPNDGLVEFVPNSKALADILKKYGSILNFLRKH----------------NPDE----------------------S 175
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1645 WPLHVMKAVLeelmeatppnllakelwsscttpdewwrvtQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHID 1724
Cdd:cd00896   176 GPYGIKPEVM------------------------------DNFVKSCAGYCVITYILGVGDRHLDNLLLT-KDGHLFHID 224

                  .
gi 767988351 1725 Y 1725
Cdd:cd00896   225 F 225
FATC pfam02260
FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution ...
3029-3058 3.31e-10

FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution structure of the FATC domain suggests it plays a role in redox-dependent structural and cellular stability.


Pssm-ID: 460514 [Multi-domain]  Cd Length: 32  Bit Score: 57.01  E-value: 3.31e-10
                           10        20        30
                   ....*....|....*....|....*....|
gi 767988351  3029 MSVAEQVDYVIKEATNLDNLAQLYEGWTAW 3058
Cdd:pfam02260    2 LSVEGQVDELIQEATDPENLAQMYIGWCPW 31
PI3Kc_IA_beta cd05173
Catalytic domain of Class IA Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of ...
1674-1872 2.91e-07

Catalytic domain of Class IA Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kbeta can be activated by G-protein-coupled receptors. Deletion of PI3Kbeta in mice results in early lethality at around day three of development. PI3Kbeta plays an important role in regulating sustained integrin activation and stable platelet agrregation, especially under conditions of high shear stress. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). Class IA enzymes contain an N-terminal p85 binding domain, a Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They associate with a regulatory subunit of the p85 family and are activated by tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270717 [Multi-domain]  Cd Length: 362  Bit Score: 55.35  E-value: 2.91e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1674 CTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIdMTTGEVVHIDYNVCFekGNIKVDFTFMRakcflvkgqky 1753
Cdd:cd05173   183 YNSGDDLERAIEEFTLSCAGYCVATYVLGIGDRHSDNIMV-RKNGQLFHIDFGHIL--GNFKSKFGIKR----------- 248
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1754 ndlsfqgkslrvpEKVPFRMTQNI-----ETALGVTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWTAGGE 1828
Cdd:cd05173   249 -------------ERVPFILTYDFihviqQGKTGNTEKFGRFRQYCEDAYLILRKNGNLFITLFALMLTAGLPELTSVKD 315
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*
gi 767988351 1829 AGFAGAVYGGGGQQAES-KQSKREMEREITRSLFSsrvaeiKVNW 1872
Cdd:cd05173   316 IQYLKDSLALGKSEEEAlKQFRQKFDEALRESWTT------KVNW 354
PI3Kc_II cd05166
Catalytic domain of Class II Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
1502-1737 3.27e-07

Catalytic domain of Class II Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C-terminus. They are activated by a variety of stimuli including chemokines, cytokines, lysophosphatidic acid (LPA), insulin, and tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270710 [Multi-domain]  Cd Length: 352  Bit Score: 55.37  E-value: 3.27e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1502 PTKTKPKKLLFLGSD--GKSYPYLFKGLEDLHLDERIMQFLSIVNTMFatinRQETPRFHARHYSVTPLGTRSGLIQWVD 1579
Cdd:cd05166    71 NSNALPLKLVFRNADprAEPISVIFKVGDDLRQDMLTLQLIRIMDKIW----LQEGLDLKMITFRCVPTGNKRGMVELVP 146
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1580 GATPLfglykRWQQREAALqaqkaqdsyqtpqnpgivprpselyyskigpalktVGlsldvSRRDWPLhvmkavleelme 1659
Cdd:cd05166   147 EAETL-----REIQTEHGL-----------------------------------TG-----SFKDRPL------------ 169
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1660 atppnllAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDynvcFEK-------- 1731
Cdd:cd05166   170 -------ADWLQKHNPSELEYEKAVENFIRSCAGYCVATYVLGICDRHNDNIMLK-TSGHLFHID----FGKflgdaqmf 237

                  ....*.
gi 767988351 1732 GNIKVD 1737
Cdd:cd05166   238 GNFKRD 243
PI3Kc cd00891
Catalytic domain of Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
1674-1812 3.55e-06

Catalytic domain of Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. Class II PI3Ks comprise three catalytic isoforms that do not associate with any regulatory subunits. They selectively use PtdIns as a susbtrate to produce PtsIns(3)P. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270624 [Multi-domain]  Cd Length: 334  Bit Score: 51.80  E-value: 3.55e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1674 CTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDynvcFEK--GNIKVDFTFMRakcflvkgq 1751
Cdd:cd00891   175 NPTEEEYEEAVENFIRSCAGYCVATYVLGIGDRHNDNIMVT-KSGHLFHID----FGHflGNFKKKFGIKR--------- 240
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 767988351 1752 kyndlsfqgkslrvpEKVPFRMTQNIETALGvtGVEGV----FRLSCEQVLHIMRRGRETLLTLL 1812
Cdd:cd00891   241 ---------------ERAPFVFTPEMAYVMG--GEDSEnfqkFEDLCCKAYNILRKHGNLLINLF 288
PI3Kc_IA_delta cd05174
Catalytic domain of Class IA Phosphoinositide 3-kinase delta; PI3Ks catalyze the transfer of ...
1671-1803 8.83e-05

Catalytic domain of Class IA Phosphoinositide 3-kinase delta; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kdelta is mainly expressed in immune cells and plays an important role in cellular and humoral immunity. It plays a major role in antigen receptor signaling in B-cells, T-cells, and mast cells. It regulates the differentiation of peripheral helper T-cells and controls the development and function of regulatory T-cells. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). Class IA enzymes contain an N-terminal p85 binding domain, a Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They associate with a regulatory subunit of the p85 family and are activated by tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270718 [Multi-domain]  Cd Length: 366  Bit Score: 47.74  E-value: 8.83e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1671 WSSCTTP-DEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIdMTTGEVVHIDYNVCFekGNIKVDFTFMRakcflvk 1749
Cdd:cd05174   182 WLKSKNPgDALDQAIEEFTLSCAGYCVATYVLGIGDRHSDNIMI-RESGQLFHIDFGHFL--GNFKTKFGINR------- 251
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 767988351 1750 gqkyndlsfqgkslrvpEKVPFRMTQNIETAL--GVTGVEGV---FRLSCEQVLHIMRR 1803
Cdd:cd05174   252 -----------------ERVPFILTYDFVHVIqqGKTNNSEKferFRGYCERAYTILRR 293
PI4Kc_III cd00893
Catalytic domain of Type III Phosphoinositide 4-kinase; PI4Ks catalyze the transfer of the ...
1685-1815 8.47e-04

Catalytic domain of Type III Phosphoinositide 4-kinase; PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. There are two types of PI4Ks, types II and III. Type II PI4Ks lack the characteristic catalytic kinase domain present in PI3Ks and type III PI4Ks, and are excluded from this family. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270626 [Multi-domain]  Cd Length: 286  Bit Score: 44.17  E-value: 8.47e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1685 QSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIdynvcfekgnikvDFTFMrakcflvkgqkyndLSFQGKSLR 1764
Cdd:cd00893   122 DNFLQSLVAYSLVCYFLQIKDRHNGNILLD-KEGHIIHI-------------DFGFF--------------LSSHPGFYG 173
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|...
gi 767988351 1765 VpEKVPFRMTQNIETALGVTGVE--GVFRLSCEQVLHIMRRGRETLLTLLEAF 1815
Cdd:cd00893   174 F-EGAPFKLSSEYIEVLGGVDSElfKEFRKLFLKGFMALRKHSDKILSLVEMM 225
PI4Kc_III_alpha cd05167
Catalytic domain of Type III Phosphoinositide 4-kinase alpha; PI4Ks catalyze the transfer of ...
1687-1817 2.36e-03

Catalytic domain of Type III Phosphoinositide 4-kinase alpha; PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. PI4KIIIalpha is a 220 kDa protein found in the plasma membrane and the endoplasmic reticulum (ER). The role of PI4KIIIalpha in the ER remains unclear. In the plasma membrane, it provides PtdIns(4)P, which is then converted by PI5Ks to PtdIns(4,5)P2, an important signaling molecule. Vertebrate PI4KIIIalpha is also part of a signaling complex associated with P2X7 ion channels. The yeast homolog, Stt4p, is also important in regulating the conversion of phosphatidylserine to phosphatidylethanolamine at the ER and Golgi interface. Mammalian PI4KIIIalpha is highly expressed in the nervous system. The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270711 [Multi-domain]  Cd Length: 307  Bit Score: 42.97  E-value: 2.36e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1687 YARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDYNVCFEK---GNIKVdftfmrakcflvkgqkyndlsfqgksl 1763
Cdd:cd05167   144 FIKSMAGYSLVSYLLQIKDRHNGNIMID-DDGHIIHIDFGFIFEIspgGNLGF--------------------------- 195
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*..
gi 767988351 1764 rvpEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIM---RRGRETLLTLLEAFVY 1817
Cdd:cd05167   196 ---ESAPFKLTKEMVDLMGGSMESEPFKWFVELCVRGYlavRPYAEAIVSLVELMLD 249
PI3Kc_C2_beta cd00895
Catalytic domain of Class II Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of ...
1666-1750 3.86e-03

Catalytic domain of Class II Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. The class II beta isoform, PI3K-C2beta, contributes to the migration and survival of cancer cells. It regulates Rac activity and impacts membrane ruffling, cell motility, and cadherin-mediated cell-cell adhesion. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C-terminus. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 119421 [Multi-domain]  Cd Length: 354  Bit Score: 42.30  E-value: 3.86e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1666 LAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDmTTGEVVHIDYNVCFEK----GNIKVD---F 1738
Cdd:cd00895   170 LADWLQKHNPTEDEYEKAVENFIYSCAGCCVATYVLGICDRHNDNIMLK-TTGHMFHIDFGRFLGHaqmfGNIKRDrapF 248
                          90
                  ....*....|..
gi 767988351 1739 TFMRAKCFLVKG 1750
Cdd:cd00895   249 VFTSDMAYVING 260
PI3Kc_IB_gamma cd00894
Catalytic domain of Class IB Phosphoinositide 3-kinase gamma; PI3Ks catalyze the transfer of ...
1664-1785 4.30e-03

Catalytic domain of Class IB Phosphoinositide 3-kinase gamma; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kgamma signaling controls diverse immune and vascular functions including cell recruitment, mast cell activation, platelet aggregation, and smooth muscle contractility. It associates with one of two regulatory subunits, p101 and p84, and is activated by G-protein-coupled receptors (GPCRs) by direct binding to their betagamma subunits. It contains an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270627 [Multi-domain]  Cd Length: 367  Bit Score: 42.16  E-value: 4.30e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 767988351 1664 NLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIdMTTGEVVHIDYNVCFekGNIKvdftfmra 1743
Cdd:cd00894   177 EVLNHWLKEKCPIEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMI-TETGNLFHIDFGHIL--GNYK-------- 245
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|..
gi 767988351 1744 kcflvkgqkyndlSFQGKSlrvPEKVPFRMTQNIETALGVTG 1785
Cdd:cd00894   246 -------------SFLGIN---KERVPFVLTPDFLFVMGTSG 271
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH